How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QOF: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents. View classification details, related manufacturers, 510(k) clearances, and recall records.
A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.Explore microbiology records →
38 clearance records and 9 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from Feb 1, 2023 to Oct 30, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 1 | 1 |
| November 2025 | 0 | 0 |
| December 2025 | 1 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 1 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| June 2026 | 1 | 1 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 3 | 0 |
| October 2026 | 3 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QOF · Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | 38 | 9 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| cobas eplex respiratory pathogen panel 3K262938 · QOF | GenMark Diagnostics, Inc. | 510(k) | Oct 30, 2026FDA decision date |
| Xpert Xpress CoV-2/Flu plusK263333 · QOF | Cepheid® | 510(k) | Oct 22, 2026FDA decision date |
| Xpert Xpress CoV-2/Flu plusK263120 · QOF | Cepheid® | 510(k) | Oct 2, 2026FDA decision date |
| Xpert Respiratory PanelK261336 · QOF | Cepheid | 510(k) | Sep 25, 2026FDA decision date |
| BIOFIRE Respiratory Panel 2.1 (RP2.1)K263054 · QOF | Biofire Diagnostics | 510(k) | Sep 22, 2026FDA decision date |
| FINDER Flu A&B/SARS-CoV-2 TestK261837 · QOF | Baebies, Inc. | 510(k) | Sep 11, 2026FDA decision date |
| BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnosticZ-2936-2026 · QOF | BioFire Diagnostics, LLC | Recall | Aug 12, 2026FDA classification date |
| Fast PCR Mini Respiratory PanelK252932 · QOF | Autonomous Medical Devices Incorporated | 510(k) | Jun 12, 2026FDA decision date |
| Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485Z-2081-2026 · QOF | BioFire Diagnostics, LLC | Recall | May 6, 2026FDA classification date |
| FINDER Flu A&B/SARS-CoV-2 TestK252269 · QOF | Baebies, Inc. | 510(k) | Mar 30, 2026FDA decision date |
| VELO Respiratory TestK251742 · QOF | Lex Diagnostics Limited | 510(k) | Feb 13, 2026FDA decision date |
| LIAISON NES FLU A/B, RSV & COVID-19K251978 · QOF | Diasorin Molecular, LLC | 510(k) | Dec 23, 2025FDA decision date |
| BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)Z-0602-2026 · QOF | BioFire Diagnostics, LLC | Recall | Nov 26, 2025FDA classification date |
| Simplexa COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)K252387 · QOF | Diasorin Molecular, LLC | 510(k) | Oct 30, 2025FDA decision date |
| QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel MiniK250080 · QOF | QIAGEN GmbH | 510(k) | Aug 27, 2025FDA decision date |
| BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel MiniK243544 · QOF | Biofire Diagnostics, LLC | 510(k) | Aug 14, 2025FDA decision date |
| DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVID-19 and Flu test. Each DASH SARS-CoV-2 & Flu A/B Test is indi…Z-2274-2025 · QOF | Nuclein LLC | Recall | Aug 6, 2025FDA classification date |
| cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 SystemsK243455 · QOF | Roche Molecular Systems, Inc. | 510(k) | Jul 31, 2025FDA decision date |
| Xpert Xpress CoV-2/Flu/RSV plusK250995 · QOF | Cepheid® | 510(k) | May 1, 2025FDA decision date |
| Xpert Xpress CoV-2/Flu/RSV plusK250996 · QOF | Cepheid® | 510(k) | May 1, 2025FDA decision date |
| cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid testK243400 · QOF | Roche Molecular Systems, Inc. | 510(k) | Apr 25, 2025FDA decision date |
| cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid testK243406 · QOF | Roche Molecular Systems, Inc. | 510(k) | Apr 25, 2025FDA decision date |
| Brand Name: QIAstat-Dx Product Name: QIAstat-Dx Respiratory Panel Plus Reference Number (REF): 691224 Software Version: n/a Component: n/aZ-1504-2025 · QOF | Qiagen Sciences LLC | Recall | Mar 31, 2025FDA classification date |
| Visby Medical Respiratory Health TestK242526 · QOF | Visby Medical, Inc. | 510(k) | Feb 19, 2025FDA decision date |
| Alinity m Resp-4-PlexK241573 · QOF | Abbott Molecular, Inc. | 510(k) | Feb 14, 2025FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.